Quick Takeaways
- Isaac Manke has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $97,003.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Isaac Manke
- Location
- New York, NY
- Summary
- The estimated net worth of Isaac Manke is at least $97,003 dollars as of 18 Mar 2026. Isaac Manke is the Director of OnKure Therapeutics, Inc. and owns shares of OnKure Therapeutics, Inc. (OKUR) stock worth about $61.7K. Isaac Manke is the Director of Q32 Bio Inc. and owns shares of Q32 Bio Inc. (QTTB) stock worth about $35.3K.
- Signature
- /s/ Lenaic Nathanael Teyssedou by power of attorney
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Isaac Manke and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: OnKure Therapeutics, Inc. ($61,749).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Isaac Manke
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| OKUR | OnKure Therapeutics, Inc. | Director | $61,749 | 31 Dec 2025 | ||
| QTTB | Q32 Bio Inc. | Director | $35,254 | 23 Oct 2025 | ||
| ADXN | Addex Therapeutics Ltd. | Director | 18 Mar 2026 |
Insider Transactions Reported by Isaac Manke:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.